Products
Platform
Research
Market
Learn
IPO
Compare ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund vs SBI Healthcare Opportunities Fund
Fund Comparison
Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Fund Details
Risk | Very High | Very High |
Rating | 5.0 | 5.0 |
Min SIP Amount | ₹100 | ₹500 |
Expense Ratio | 1.86 | 1.93 |
NAV | ₹40.22 | ₹432.67 |
Fund Started | 25 Jun 2018 | 04 Jun 1999 |
Fund Size | ₹6437.36 Cr | ₹4082.13 Cr |
Exit Load | Exit load of 1% if redeemed within 15 days. | Exit load of 0.50% if redeemed within 15 days |
Risk
Very High
Very High
Rating
5.0
5.0
Min SIP Amount
₹100
₹500
Expense Ratio
1.86
1.93
NAV
₹40.22
₹432.67
Fund Started
25 Jun 2018
04 Jun 1999
Fund Size
₹6437.36 Cr
₹4082.13 Cr
Exit Load
Exit load of 1% if redeemed within 15 days.
Exit load of 0.50% if redeemed within 15 days
Returns
1 Year | 3.63% | 1.30% |
3 Year | 26.54% | 23.64% |
5 Year | 19.11% | 18.17% |
1 Year
3.63%
1.30%
3 Year
26.54%
23.64%
5 Year
19.11%
18.17%
Holding Analysis
Equity | 97.10% | 96.05% |
Cash | 2.90% | 3.88% |
Equity
97.10%
96.05%
Cash
2.90%
3.88%
Top Holdings
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 11.88% |
Dr. Reddy's Laboratories Ltd. | 9.42% |
Divi's Laboratories Ltd. | 8.50% |
Aurobindo Pharma Ltd. | 7.62% |
Cipla Ltd. | 6.61% |
Lupin Ltd. | 5.40% |
Alkem Laboratories Ltd. | 3.98% |
Biocon Ltd. | 3.28% |
Mankind Pharma Ltd. | 2.79% |
Zydus Lifesciences Ltd. | 2.67% |
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 11.18% |
Divi's Laboratories Ltd. | 7.26% |
Max Healthcare Institute Ltd. | 5.62% |
Cipla Ltd. | 4.41% |
Lonza Group Ag | 4.05% |
Lupin Ltd. | 4.04% |
Acutaas Chemicals Ltd. | 3.81% |
Fortis Healthcare Ltd. | 3.76% |
Torrent Pharmaceuticals Ltd. | 3.49% |
Jupiter Life Line Hospitals Ltd. | 3.46% |
Fund Manager
Name | Dharmesh Kakkad | Tanmaya Desai |
Start Date | 23 Feb 2021 | 17 May 2024 |
Name
Dharmesh Kakkad
Tanmaya Desai
Start Date
23 Feb 2021
17 May 2024
About Fund
Description | The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies. | The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space. |
Launch Date | 25 Jun 2018 | 04 Jun 1999 |
Description
The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.
The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.
Launch Date
25 Jun 2018
04 Jun 1999